Journal article
Spotlight on real-world evidence for the treatment of DVT: XALIA
Abstract
Venous thromboembolism (VTE), comprising both deep-vein thrombosis (DVT) and pulmonary embolism (PE), is a serious and common cardiovascular disease associated with the risk of chronic complications, recurrent VTE events and even death. The treatment landscape has, in recent years, seen a paradigm shift from the use of traditional anticoagulants (low-molecular-weight heparin [LMWH] overlapping with and followed by a vitamin K antagonist [VKA]) …
Authors
Ageno W; Turpie AGG
Journal
Thrombosis and Haemostasis, Vol. 116, No. Suppl. 2, pp. s41–s49
Publisher
Thieme
Publication Date
2016
DOI
10.1160/th16-06-0488
ISSN
0340-6245